“…This plan quality metric has been correlated to toxicities, for example, in radiosurgery for meningioma. 7 Additionally, the homogeneity of the dose distribution inside the target, as measured by the maximal point dose, 8 or as an integrated dose to a clinically relevant subvolume of the target, 9 has been correlated to toxicities after treatment for benign diseases such as vestibular schwanoma and meningioma with stereotactic radiosurgery. Given these two examples of clinical correlates to plan quality metrics, any technological development that allows either an increase in dose gradient, or an increase in dose homogeneity, may have a potential role in improving patient care in stereotactic radiosurgery.…”